NextCure, Inc. Annual Operating Income (Loss) in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
NextCure, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2018 to 2023.
  • NextCure, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$12.5M, a 20% increase year-over-year.
  • NextCure, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$63.1M, a 9.39% increase year-over-year.
  • NextCure, Inc. annual Operating Income (Loss) for 2023 was -$67.6M, a 10.9% increase from 2022.
  • NextCure, Inc. annual Operating Income (Loss) for 2022 was -$75.9M, a 7.27% decline from 2021.
  • NextCure, Inc. annual Operating Income (Loss) for 2021 was -$70.8M, a 71.7% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$67.6M +$8.27M +10.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-21
2022 -$75.9M -$5.14M -7.27% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 -$70.8M -$29.5M -71.7% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-02
2020 -$41.2M -$3.74M -9.99% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-03
2019 -$37.5M -$14.3M -61.6% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-04
2018 -$23.2M Jan 1, 2018 Dec 31, 2018 10-K 2020-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.